publication venue for
- Ultra-long acting prodrug of dolutegravir and delivery system Physicochemical, pharmacokinetic and formulation characterizations 2021
- Controlled curcumin release from nanofibers based on amphiphilic-block segmented polyurethanes.. 575:118947-118947. 2020
- Evaluation of commercially available meth-deterrent pseudoephedrine hydrochloride products.. 575:118909-118909. 2020
- Engineered extracellular vesicles with synthetic lipids via membrane fusion to establish efficient gene delivery.. 573:118802-118802. 2020
- Quantitative estimation of phenytoin sodium disproportionation in the formulations using vibration spectroscopies and multivariate methodologies.. 539:65-74. 2018
- Leachable diphenylguanidine from rubber closures used in pre-filled syringes: A case study to understand solid and solution interactions with oxytocin.. 532:491-501. 2017
- Risk based in vitro performance assessment of extended release abuse deterrent formulations.. 500:255-267. 2016
- Influence of drug loading and type of ointment base on the in vitro performance of acyclovir ophthalmic ointment.. 495:783-791. 2015
- Understanding effect of formulation and manufacturing variables on the critical quality attributes of warfarin sodium product.. 495:19-30. 2015
- Kinetics of drug release from ointments: Role of transient-boundary layer.. 494:31-39. 2015
- Formulation and process factors influencing product quality and in vitro performance of ophthalmic ointments.. 493:412-425. 2015
- Determination of tacrolimus crystalline fraction in the commercial immediate release amorphous solid dispersion products by a standardized X-ray powder diffraction method with chemometrics.. 475:462-470. 2014
- Challenges of pediatric formulations: a FDA science perspective.. 457:346-348. 2013
- Focused beam reflectance measurement to monitor nimodipine precipitation process.. 456:353-356. 2013
- Hunter screening design to understand the product variability of solid dispersion formulation of a peptide antibiotic.. 456:572-582. 2013
- Will nanomedicine deliver on its promise of changing therapeutics or remain an interesting and important research tool in cell biology and physiology?. 454:530-531. 2013
- Cholorpheniramine tannate complexes: physicochemical, chemometric, and taste masking evaluation.. 436:582-592. 2012
- A two-stage reverse dialysis in vitro dissolution testing method for passive targeted liposomes.. 426:211-218. 2012
- Crystallinity evaluation of tacrolimus solid dispersions by chemometric analysis.. 423:341-350. 2012
- Predicting hydrophilic drug encapsulation inside unilamellar liposomes.. 423:410-418. 2012
- Quality by design approach for formulation development: a case study of dispersible tablets.. 423:167-178. 2012
- Tannate complexes of antihistaminic drug: sustained release and taste masking approaches.. 422:91-100. 2012
- A quality by design (QbD) case study on liposomes containing hydrophilic API: I. Formulation, processing design and risk assessment.. 419:52-59. 2011
- Quality-by-Design (QbD): An integrated process analytical technology (PAT) approach for a dynamic pharmaceutical co-precipitation process characterization and process design space development.. 405:63-78. 2011
- In vitro and in vivo evaluation of anti-inflammatory agents using nanoengineered alginate carriers: towards localized implant inflammation suppression.. 403:268-275. 2011
- Tablet splitting: Product quality assessment of metoprolol succinate extended release tablets.. 401:25-31. 2010
- Enhanced gene transfection efficiency by polyamidoamine (PAMAM) dendrimers modified with ornithine residues.. 392:294-303. 2010
- Understanding the quality of protein loaded PLGA nanoparticles variability by Plackett-Burman design.. 389:186-194. 2010
- Comparative stability of repackaged metoprolol tartrate tablets.. 385:92-97. 2010
- Quality-by-design (QbD): an integrated multivariate approach for the component quantification in powder blends.. 372:39-48. 2009
- Targeted delivery of methotrexate to skeletal muscular tissue by thermosensitive magnetoliposomes.. 370:136-143. 2009
- Stability indicating validated HPLC method for quantification of levothyroxine with eight degradation peaks in the presence of excipients.. 360:77-82. 2008
- Molecular weight determination for colloidal iron by Taguchi optimized validated gel permeation chromatography.. 353:21-27. 2008
- Quantitative determination of thallium binding to ferric hexacyanoferrate: Prussian blue.. 353:187-194. 2008
- Comparison of the stability of split and intact gabapentin tablets.. 350:65-69. 2008
- Permeability of surface-modified polyamidoamine (PAMAM) dendrimers across Caco-2 cell monolayers.. 350:113-121. 2008
- Process analytical technology (PAT): effects of instrumental and compositional variables on terahertz spectral data quality to characterize pharmaceutical materials and tablets.. 343:148-158. 2007
- Quality by design: characterization of self-nano-emulsified drug delivery systems (SNEDDs) using ultrasonic resonator technology.. 341:189-194. 2007
- Effect of mean diameter and polydispersity of PLG microspheres on drug release: experiment and theory.. 337:118-126. 2007
- Quality by design: understanding the formulation variables of a cyclosporine A self-nanoemulsified drug delivery systems by Box-Behnken design and desirability function.. 332:55-63. 2007
- Controlled release of a self-emulsifying formulation from a tablet dosage form: stability assessment and optimization of some processing parameters.. 315:110-121. 2006
- Optimization and characterization of controlled release multi-particulate beads coated with starch acetate.. 294:89-101. 2005
- Biodisposition of PEG-coated lipid microspheres of indomethacin in arthritic rats.. 290:55-62. 2005
- Preparation and in vitro characterization of self-nanoemulsified drug delivery system (SNEDDS) of all-trans-retinol acetate.. 285:109-119. 2004
- Bioavailability assessment of salbutamol sulfate suppositories in human volunteers.. 279:3-7. 2004
- Evaluation of cytotoxicity of oils used in coenzyme Q10 Self-emulsifying Drug Delivery Systems (SEDDS).. 273:63-73. 2004
- Effect of Azone upon the in vivo antiviral efficacy of cidofovir or acyclovir topical formulations in treatment/prevention of cutaneous HSV-1 infections and its correlation with skin target site free drug concentration in hairless mice.. 253:159-168. 2003
- Optimization of a self-nanoemulsified tablet dosage form of Ubiquinone using response surface methodology: effect of formulation ingredients.. 240:103-114. 2002
- Optimization and characterization of controlled release multi-particulate beads formulated with a customized cellulose acetate butyrate dispersion.. 234:179-193. 2002
- Preparation and in vitro characterization of a eutectic based semisolid self-nanoemulsified drug delivery system (SNEDDS) of ubiquinone: mechanism and progress of emulsion formation.. 235:247-265. 2002
- Polymethyacrylate based microparticulates of insulin for oral delivery: preparation and in vitro dissolution stability in the presence of enzyme inhibitors.. 225:31-39. 2001
- Self-emulsifying drug delivery systems (SEDDS) of coenzyme Q10: formulation development and bioavailability assessment.. 212:233-246. 2001
- Captopril gastrointestinal therapeutic system coated with cellulose acetate pseudolatex: evaluation of main effects of several formulation variables.. 193:147-156. 2000
- Transbuccal permeation of a nucleoside analog, dideoxycytidine: effects of menthol as a permeation enhancer.. 192:139-146. 1999
- Box-behnken design for the optimization of formulation variables of indomethacin coprecipitates with polymer mixtures. 131:9-17. 1996
- Inhibition of granulocyte colony stimulating factor (G-CSF) adsorption to polyvinyl chloride using a nonionic surfactant. 114:177-184. 1995
- FDA: contribution to developing pediatric formulations and transatlantic collaboration. 2012